---
title: "Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295100080.md"
description: "Intellia Therapeutics, Inc., a biopharmaceutical company based in Cambridge, Massachusetts, announced their business updates and financial results for the second quarter ending on June 30, 2026. Known for their focus on revolutionizing medicine through CRISPR gene editing and other core technologies, Intellia Therapeutics, Inc. (Nasdaq: NTLA) shared their latest information."
datetime: "2026-08-06T11:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295100080.md)
  - [en](https://longbridge.com/en/news/295100080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295100080.md)
generator: "portal-rs"
---

# Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Intellia Therapeutics, Inc., a biopharmaceutical company based in Cambridge, Massachusetts, announced their business updates and financial results for the second quarter ending on June 30, 2026. Known for their focus on revolutionizing medicine through CRISPR gene editing and other core technologies, Intellia Therapeutics, Inc. (Nasdaq: NTLA) shared their latest information.

### Related Stocks

- [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md)

## Related News & Research

- [Intellia grants inducement RSUs for 38,200 shares to eight new employees](https://longbridge.com/en/news/295272227.md)
- [Intellia Q2 2026 Earnings: Lonvo-z Moves Toward a BLA](https://longbridge.com/en/news/295103160.md)
- [CPS Technologies leases 80,000-sq-ft Attleboro, Massachusetts facility to expand operations](https://longbridge.com/en/news/296531870.md)
- [Vivmark Residential Required to Sell Two Boston Properties to Resolve Merger Concerns](https://longbridge.com/en/news/296261466.md)
- [08:33 ETCunningham Security Systems Acquires S.W. Alarms, Expanding Service in Southeastern Massachusetts](https://longbridge.com/en/news/296788818.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**